Maynard Um
-
-
-
-
-
-
-
Wells Fargo Downgrades Verona Pharma (VRNA) to Equal Weight
-
-
-
-
-
-
-
Wolfe Research Starts Verona Pharma (VRNA) at Outperform
-
-
-
-
-
-
-
Jefferies Bangs Table on Verona Pharma (VRNA), Top Pick, 'We think Ohtuvayre (novel PDE3/4) is tracking to become an attractive $2.5B+ add-on therapy'
-
-
-
-
-
-
-
Xeris Pharmaceuticals (XERS) Announces Board Changes
-
-
-
-
-
-
-
Verona Pharma (VRNA) PT Raised to $72 at Canaccord Genuity
-
-
-
-
-
-
-
Verona Pharma (VRNA) PT Raised to $42 at H.C. Wainwright
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Verona Pharma (VRNA)
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

